reported that azacitidine upregulated CD70 expression in AML cells and facilitated the expansion of CD8H&TM CD70 CAR‐T cells modified with CD8 hinge and transmembrane domains, thereby enhancing antitumour efficacy.135. The gene discussed is CD70; the disease is acute myeloid leukemia.